Skip to main content
Loading

Genesis Healthcare Co.

Monday, February 26, 2024
Uris
Tools/Drug Development Support Tech
Celebrating its 20th anniversary, Genesis Healthcare is Japan’s leading genetic testing and research company, servicing medical institutions, government, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare provides advanced genetic testing services, from prevention to diagnostics as well as advanced genomic analytical services. To date, Genesis Healthcare has performed more than 2 million genetic tests and accumulated the largest genomic database of the Japanese population. GenesisGaia, its genomics platform powered by generative A.I. empowers researchers in life sciences to accelerate R&D and discoveries. With its extensive database and prediction models validated for Asian populations, Genesis Healthcare addresses the diversity bias in global life sciences by providing researchers with easy access to Japanese and Asian genomic data.
Speakers
Michel Mommejat, Chief Innovation Officer - Genesis Healthcare

State

Tokyo

Country

Japan

Website

http://www.genesis-healthcare.jp

CEO/Top Company Official

David Baran, President and co-founder Iri Sato Baran, Chief Operating officer Michel Mommejat, Chief Innovation Officer

Lead Product in Development

GenesisGaia (genomic A.I. generative platform) Liquid biosy (cancer panel)

Development Phase of Primary Product

Other/Not Applicable

Number Of Unlicensed Products

N.A.
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP